1. Home
  2. UP vs ENTX Comparison

UP vs ENTX Comparison

Compare UP & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wheels Up Experience Inc.

UP

Wheels Up Experience Inc.

N/A

Current Price

$3.13

Market Cap

134.2M

ML Signal

N/A

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

N/A

Current Price

$3.22

Market Cap

147.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UP
ENTX
Founded
2013
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.2M
147.4M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
UP
ENTX
Price
$3.13
$3.22
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $9.75
AVG Volume (30 Days)
75.1K
★ 627.5K
Earning Date
11-13-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 14.29
N/A
EPS
N/A
★ 0.22
Revenue
★ $736,495,000.00
$42,000.00
Revenue This Year
$193.34
N/A
Revenue Next Year
$12.65
N/A
P/E Ratio
★ N/A
$14.05
Revenue Growth
★ N/A
N/A
52 Week Low
$0.36
$0.91
52 Week High
$10.09
$4.20

Technical Indicators

Market Signals
Indicator
UP
ENTX
Relative Strength Index (RSI) 40.29 63.60
Support Level $0.47 $2.64
Resistance Level $4.01 $3.26
Average True Range (ATR) 0.22 0.23
MACD 0.01 0.05
Stochastic Oscillator 37.74 92.73

Price Performance

Historical Comparison
UP
ENTX

About UP Wheels Up Experience Inc.

Wheels Up Experience Inc is a provider of on-demand private aviation. The company offers a private aviation solution with a large and diverse aircraft fleet, delivered through a mix of charter solutions and its membership program that utilizes its controlled aircraft fleet and a network of safety-vetted charter operators. Through its partnership firm, it provides members and customers with an offering across private and premium commercial travel. It generates the majority of its revenue from member and customer flights through its membership program and charter solutions, as well as from membership fees and other activities and services, including group charter flights, cargo flights, and special missions. Geographically, the company generates maximum revenue from the United States.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Share on Social Networks: